The neuroendocrinology of chronic fatigue syndrome: Focus on the hypothalamic-pituitary-adrenal axis

Functional Neurology

Volumn 14, Issue 1, 1999, Pages 3-11

  Scott, Lucinda V ^a   Dinan, Timothy G ^b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Adrenocorticotropin (ACTH); Chronic fatigue syndrome (CFS); Cortisol; Hypothalamic pituitary adrenal axis (HPA); Serotonin (SHT)

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; FLUOXETINE; GROWTH HORMONE; HYDROCORTISONE; OPIATE; PRASTERONE; PROLACTIN; SEROTONIN; VASOPRESSIN;

ADRENAL INSUFFICIENCY; CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; EPSTEIN BARR VIRUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MELANCHOLIA; NEURASTHENIA; NEUROENDOCRINOLOGY; REVIEW; STRESS; THALAMUS MIDLINE NUCLEUS;

CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER, MAJOR; EXERCISE THERAPY; FATIGUE SYNDROME, CHRONIC; FEMALE; FIBROMYALGIA; GLUCOCORTICOIDS; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MODELS, BIOLOGICAL; OPIOID PEPTIDES; PITUITARY-ADRENAL SYSTEM; SEROTONIN; STEROIDS; STRESS; VASOPRESSINS;

EID: 0032910667     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Fukuda K, Straus S, Hickie I et al. The chronic fatigue syndrome: a comprehensive approach to its treatment and study. Ann Intern Med 1994;121:253-259
2. Wessely S, Chalder T, Hirsch S et al. The epidemiology of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health 1997;87:1449-1455
3. Beard GM. Neuroasthenia or nervous exhaustion. Boston Medicine and Surgery Journal 1869;80:217-221
4. Gilliam AG. Epidemiological study of an epidemic, diagnosed as poliomyelitis, occurring among the personnel at Los Angeles County General Hospital during the summer of 1934. Public Health Bulletin No. 240, US Treasury Department, Washington DC, 1938
5. Tobi M, Ravid Z, Feldman-Weiss V et al. Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Ann Intern Med 1982;1:61-64
6. Isaacs R. Chronic fatigue mononucleosis. Blood 1948;3:858-861
7. Behan PO, Behan WMH. Post-viral fatigue syndrome. CRC Crit Rev Clin Neurobiol 1988;4:157-178
8. Holmes GP, Kaplan J, Gantz N et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988;108:387-389
9. Mawle AC, Nissenbaum R, Dobbins JG et al. Immune responses associated with chronic fatigue syndrome: a case control study. J Infect Dis 1997;175:136-141
10. Behan WMH. Mitochondrial abnormalities in the post-viral fatigue syndrome. Acta Neuropathol (Berl) 1991;83:61-65
11. Wessely S, Powell R. Fatigue syndromes: a comparison of chronic post-viral fatigue syndrome with neuromuscular and affective disorders. J Neurol Neurosurg Psychiatry 1989;52:940-948
12. Manu P, Lane TJ, Matthews DA. The frequency of chronic fatigue syndrome in patients with symptoms of persisting fatigue. Ann Intern Med 1988;108:387-389
13. Taerk K, Toner B, Salit I et al. Depression in patients with neuromyasthenia (benign myalgic encephalomyelitis). Int J Psychiatry Med 1987; 17:49-56
14. Demitrack MA, Greden JF. Chronic fatigue syndrome: the need for an integrative approach. Biol Psychiatry 1991;30:747-752
15. Baxter JD, Tyrell J. The adrenal cortex. In: Felig P, Baxter J, Frohman L eds Endocrinology and Metabolism. New York; McGraw-Hill Inc. 1981:385-510
16. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. New Engl J Med 1995;332:1351-1362
17. Selye H. Stress without distress. Philadelphia, Lippincott, PA. 1974
18. Michelson D, Licinio J, Gold PW. Mediation of the stress response by the hypothalamic-pituitary-adrenal axis. In: Friedman M, Charney D, Deutch AY eds Neurobiological and Clinical Consequences of Stress. From Normal Adaptation to PTSD. Philadelphia, Lippincott Raven 1995:225-248
19. Demitrack MA, Dale JK, Straus SE et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. J Clin Endocrinol Metab 1991;73:1224-1234
20. Polietakhoff A. Adrenocortical activity and some clinical findings in acute and chronic fatigue. J Psychosom Res 1981;25:91-95
21. Cleare AJ, Beam J, Allain T et al. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J Affect Disord 1995;35:283-289
22. Dinan T, Majeed T, Lavelle E et al. Blunted serotonergic-mediated prolactin release in chronic fatigue syndrome. Psychoneuroendocrinology 1997;22:261-267
23. Scott L, Burnett F, Medbak S, Dinan T. Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychol Med 1998;28:285-293
24. Scott L, Dinan T. Urinary free cortisol excretion in depression, in chronic fatigue syndrome and in health. J Affect Disord 1998;47:49-54
25. Scott L, Medbak S, Dinan T. The low-dose adrenocorticotropin test in chronic fatigue syndrome and in health. Clin Endocrinol (Oxf) 1998;48:733-737
26. Dickstein G, Schechner C, Nicholson W et al. Adrenocorticotropin stimulation tests: effects of basal levels, time of day and sensitive new low dose test. J Clin Endocrinol Metab 1991;72:773-778
27. Scott L, Salahudin F, Cooney J, Svec F, Dinan T. Differing adrenal steroid profile in chronic fatigue syndrome, in depression and in health. J Affect Disord (in press)
28. Carroll BJ. Dexamethasone suppression test for melancholia. Brit J Psychiatry 1982; 140:292-304
29. Scott L, Dinan T. Blunted adrenocorticotropin response to corticotropin-releasing hor-mone test in chronic fatigue syndrome. Acta Psychiatr Scand 1998;97:450-457
30. Holsboer F, Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 1996;17:187-205
31. Carroll BJ, Curtis G, Davies B et al. Urinary free cortisol excretion in depressives. Psychol Med 1976;6:43-47
32. Amsterdam J, Winokur A, Abelman E et al. CoSyntropin (ACTH 1-24) stimulation test in depressed patients and healthy subjects. Am J Psychiatry 1983;140:907-909
33. Rubin R, Philips J. Adrenal gland volume in major depressives. Arch Gen Psychiatry 1993;50:833-834
34. Nemeroff C, Widerlov E, Bissette G et al. Elevated concentrations of corticotropin releasing factor-like immunoreactivity in depressed patients. Science 1984;226:1342-1344
35. Sutton R, Koob G, Le Maol M et al. Corticotropin-releasing factor produces beha-vioural activation in rats. Nature 1982;297: 331-333
36. DeBold C, Sheldon W, Cherney G et al. Arginine vasopressin potentiates adrenocorticotropin release induced by corticotropin releasing factor. J Clin Invest 1984;73:533-538
37. Bakheit A, Behan P, Watson W, Morton J. Abnormal arginine-vasopressin secretion and water metabolism in patients with post-viral fatigue syndrome. Acta Neurol Scand 1993;87:234-238
38. Bou-Halaigah I, Rowe P, Kan J, Calkins H. The relationship between neurally-mediated hypotension and the chronic fatigue syndrome. JAMA 1996;274:961-967
39. Demitrack MA. Neuroendocrine correlates of chronic fatigue syndrome: a brief review. J Psychiatr Res 1997;31:69-82
40. Purba J, Hoogendijk W, Stam F, Tilders F, Swaab D. Increased numbers of vasopressin- and oxytocin-containing neurons in the paraventricular nucleus of the hypothalamus of depressed patients. Arch Gen Psychiatry 1996;53:137-143
41. Lesch K, Rupprecht R, Poten B et al. Endocrine responses to 5HT1a receptor activation in humans. Biol Psychiatry 1989;28:203-205
42. Lesch K, Mayer S, Disselkamp-Tietze J et al. 5HT1a receptor responsivity in unipolar major depression: evaluation of ipsapironeinduced ACTH and cortisol secretion in patients and controls. Biol Psychiatry 1988; 28:203-205
43. Bakheit A, Behan P, Dinan T et al. Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with post-viral fatigue syndrome. BMJ 1992;304:1010-1012
44. Sharpe M, Clements A, Hawton K et al. Increased prolactin response to buspirone in chronic fatigue syndrome. J Affect Disord 1996;41:71-76
45. Sharpe K, Hawton K, Clements A, Cowen P. Increased brain serotonin function in men with chronic fatigue syndrome. BMJ 1997;315:164-165
46. Yatham L, Morehouse R, Chisholm B et al. Neuroendocrine assessment of serotonin (5HT) function in chronic fatigue syndrome. Can J Psychiatry 1995;40:93-96
47. O'Keane V, Dinan T. Prolactin and cortisol responses to d-fenfluraraine challenge in major depression; evidence for diminished responsivity of central serotonergic function. Am J Psychiatry 1991;148:1009-1015
48. Dinan TG. Serotonin and HPA function. Life Sci 1996;58:1683-1694
49. Vercoulen J, Swanink C, Zitman F et al. Randomised, placebo-controlled trial of fluoxetine in chronic fatigue syndrome. Lancet 1996;347;658-661
50. Casaneuva F, Burguera B, Murais C, Dieguez C. Acute administration of corticoids: a new and peculiar stimulus of growth hormone release in man. J Clin Endocrinol Metab 1990;70:234-237
51. Majeed T, Dinan TG, Thakore J et al. Defective dexamethasone-induced growth hormone release in chronic fatigue syndrome: evidence for glucocorticoid receptor resistance and lack of plasticity? Journal of the Irish College of Physicians and Surgeons 1995;24:20-24
52. th, 1996
53. Beam J, Allain T, Coskeran P et al. Neu-roendocrine response to d-fenflurarnine and insulin-induced hypoglycaemia in chronic fatigue syndrome. Biol Psychiatry 1995;37: 245-252
54. Allain T, Beam J, Coskeran P et al. Changes in growth hormone, insulin, insulin-like growth factors (IGFs), and IGF-binding protein-1 in chronic fatigue syndrome. Biol Psychiatry 1997;41:567-573
55. Grossman A, Besser G. Opiates control ACTH release through a noradrenergic mechanism. Clin Endocrinol 1982; 17:287-290
56. Zis A, Garland J. Opioid peptides and depression. In: Ur E ed Clinical Endocrinology and Metabolism. London; Balliere Tindall 1991:97-117
57. Chrousos G, Gold P. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992;267:1244-1252
58. McKenzie R, O'Fallon A, Dale J et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome. JAMA 1998;280:1061-1066
59. Fulcher K, White P. A randomised controlled trial of graded exercise in chronic fatigue syndrome. BMJ 1997;313:1647-1652